Robert J DelAversano insider trades: ONCOSEC MEDICAL (ONCS) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Robert reports to the SEC
Open-market buys and sales
8 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 9, 2023 | ONCS | ↓ Sell | 40 | $1.37 | $55 | Direct | Feb 9, 2023 (0d) |
| Nov 4, 2022 | ONCS | ↓ Sell | 283 | $0.37 | $105 | Direct | Nov 4, 2022 (0d) |
| Aug 5, 2022 | ONCS | ↓ Sell | 284 | $0.71 | $202 | Direct | Aug 5, 2022 (0d) |
| May 6, 2022 | ONCS | ↓ Sell | 274 | $0.83 | $227 | Direct | May 6, 2022 (0d) |
| Feb 9, 2022 | ONCS | ↓ Sell | 409 | $0.88 | $360 | Direct | Feb 11, 2022 (2d) |
| Nov 1, 2021 | ONCS | ↓ Sell | 343 | $1.75 | $600 | Direct | Nov 3, 2021 (2d) |
| Aug 2, 2021 | ONCS | ↓ Sell | 412 | $2.18 | $898 | Direct | Aug 3, 2021 (1d) |
| May 3, 2021 | ONCS | ↓ Sell | 453 | $4.86 | $2K | Direct | May 4, 2021 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Robert J DelAversano's insider trades
Robert J DelAversano is VP, Finance at ONCOSEC MEDICAL (ONCS). Since May 3, 2021, Robert has reported no open-market purchases and 8 sales worth $5K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (8 filings), shares withheld for taxes (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ONCS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.